Hydrophobic-core PEGylated graft copolymer-stabilized nanoparticles composed of insoluble non-nucleoside reverse transcriptase inhibitors exhibit strong anti-HIV activity

This publication has 33 references indexed in Scilit:

• Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
  International Journal of Nanomedicine, 2012
• pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission
  European Journal of Pharmaceutics and Biopharmaceutics, 2011
• SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans
  PLOS ONE, 2011
• Extending Residence Time and Stability of Peptides by Protected Graft Copolymer (PGC) Excipient: GLP-1 Example
  Pharmaceutical Research, 2011
• One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
  Journal of Virology, 2011
• Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)
  AIDS, 2011
• Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection
  Journal of Reproductive Immunology, 2011
• Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
  BMC Infectious Diseases, 2009
• Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides
  Antimicrobial Agents and Chemotherapy, 2008
• Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
  Proceedings of the National Academy of Sciences, 2007